Cystic fibrosis year in review 2018, part 1
作者： Adrienne P. Savant , Susanna A. McColley
DOI: 10.1002/PPUL.24361
关键词:
摘要: Cystic fibrosis research and case reports were robust in the year 2018. This report summarizes cases related to Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies, inflammation infection, epidemiology physiologic, imaging assessment of disease.
sci-hub.se 参考文章(97)
M. Corey, F.J. McLaughlin, M. Williams, H. Levison, A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto☆ Journal of Clinical Epidemiology. ,vol. 41, pp. 583- 591 ,(1988) , 10.1016/0895-4356(88)90063-7
Cameron L. Jordan, Terry L. Noah, Marianna M. Henry, Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis Pediatric Pulmonology. ,vol. 51, pp. S61- S70 ,(2016) , 10.1002/PPUL.23505
Michal Gur, Elena Spinelli, Gloria Tridello, Susanna Baltieri, Lucia Pinali, Stefania Montemezzi, Lea Bentur, Baroukh Maurice Assael, Chest computed tomography scores in patients with cystic fibrosis colonized with methicillin-resistant Staphylococcus aureus. Clinical Respiratory Journal. ,vol. 12, pp. 779- 785 ,(2018) , 10.1111/CRJ.12594
L. Nkam, J. Lambert, A. Latouche, G. Bellis, PR. Burgel, M.N. Hocine, A 3-year prognostic score for adults with cystic fibrosis Journal of Cystic Fibrosis. ,vol. 16, pp. 702- 708 ,(2017) , 10.1016/J.JCF.2017.03.004
Insa Korten, Margot Liechti, Florian Singer, Gaudenz Hafen, Isabelle Rochat, Pinelopi Anagnostopoulou, Dominik Müller-Suter, Jakob Usemann, Alexander Moeller, Urs Frey, Philipp Latzin, Carmen Casaulta, SCILD and BILD study group, Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls. Journal of Cystic Fibrosis. ,vol. 17, pp. 105- 108 ,(2018) , 10.1016/J.JCF.2017.05.005
Dominique Hubert, Clémence Dehillotte, Anne Munck, Valérie David, Jinmi Baek, Laurent Mely, Stéphane Dominique, Sophie Ramel, Isabelle Danner Boucher, Sylvaine Lefeuvre, Quitterie Reynaud, Virginie Colomb-Jung, Prissile Bakouboula, Lydie Lemonnier, Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2 years of treatment with ivacaftor in a real-world setting Journal of Cystic Fibrosis. ,vol. 17, pp. 89- 95 ,(2018) , 10.1016/J.JCF.2017.07.001
V.A. LeGrys, T.C. Moon, J. Laux, M.J. Rock, F. Accurso, Analytical and biological variation in repeated sweat chloride concentrations in clinical trials for CFTR modulator therapy. Journal of Cystic Fibrosis. ,vol. 17, pp. 43- 49 ,(2018) , 10.1016/J.JCF.2017.07.008
Marcus Svedberg, Per M. Gustafsson, Paul D. Robinson, Monica Rosberg, Anders Lindblad, Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children Journal of Cystic Fibrosis. ,vol. 17, pp. 236- 241 ,(2017) , 10.1016/J.JCF.2017.08.004
Mirjam Stahl, Simon Y. Graeber, Cornelia Joachim, Sandra Barth, Isabell Ricklefs, Gesa Diekmann, Matthias V. Kopp, Lutz Naehrlich, Marcus A. Mall, Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases Journal of Cystic Fibrosis. ,vol. 17, pp. 249- 255 ,(2017) , 10.1016/J.JCF.2017.08.001
Scott H. Donaldson, Joseph M. Pilewski, Matthias Griese, Jon Cooke, Lakshmi Viswanathan, Elizabeth Tullis, Jane C. Davies, Julie A. Lekstrom-Himes, Linda T. Wang, Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR American Journal of Respiratory and Critical Care Medicine. ,vol. 197, pp. 214- 224 ,(2018) , 10.1164/RCCM.201704-0717OC